US20030103985A1 - Cytotoxic CD44 antibody immunoconjugates - Google Patents

Cytotoxic CD44 antibody immunoconjugates Download PDF

Info

Publication number
US20030103985A1
US20030103985A1 US10/150,475 US15047502A US2003103985A1 US 20030103985 A1 US20030103985 A1 US 20030103985A1 US 15047502 A US15047502 A US 15047502A US 2003103985 A1 US2003103985 A1 US 2003103985A1
Authority
US
United States
Prior art keywords
antibody molecule
conjugate
antibody
seq id
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/150,475
Inventor
Guenther Adolf
Erik Patzelt
Marlies Sproll
Karl-Heinz Heider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EPEU01112227.2 priority Critical
Priority to EP01112227A priority patent/EP1258255A1/en
Priority to US30745101P priority
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Priority to US10/150,475 priority patent/US20030103985A1/en
Assigned to BOEHRINGER INGELHEIM INTERNATIONAL GMBH reassignment BOEHRINGER INGELHEIM INTERNATIONAL GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ADOLF, GUENTHER, HEIDER, KARL-HEINZ, PATZELT, ERIK, SPROLL, MARLIES
Publication of US20030103985A1 publication Critical patent/US20030103985A1/en
Application status is Abandoned legal-status Critical

Links